143 related articles for article (PubMed ID: 10673512)
41. The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study.
Scolaro MJ; Gunnill LB; Pope LE; Khalil MH; Katz DH; Berg JE
AIDS Res Hum Retroviruses; 2001 Jan; 17(1):35-43. PubMed ID: 11177381
[TBL] [Abstract][Full Text] [Related]
42. Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.
Polizzotto MN; Uldrick TS; Wyvill KM; Aleman K; Peer CJ; Bevans M; Sereti I; Maldarelli F; Whitby D; Marshall V; Goncalves PH; Khetani V; Figg WD; Steinberg SM; Zeldis JB; Yarchoan R
J Clin Oncol; 2016 Dec; 34(34):4125-4131. PubMed ID: 27863194
[TBL] [Abstract][Full Text] [Related]
43. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
44. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
[No Abstract] [Full Text] [Related]
45. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
Albini A; Morini M; D'Agostini F; Ferrari N; Campelli F; Arena G; Noonan DM; Pesce C; De Flora S
Cancer Res; 2001 Nov; 61(22):8171-8. PubMed ID: 11719447
[TBL] [Abstract][Full Text] [Related]
47. Chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Pechère M; Krischer J; Rutschmann OT
Dermatology; 1997; 195(4):411-2. PubMed ID: 9529573
[No Abstract] [Full Text] [Related]
48. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study.
Krischer J; Rutschmann O; Hirschel B; Vollenweider-Roten S; Saurat JH; Pechère M
J Am Acad Dermatol; 1998 Apr; 38(4):594-8. PubMed ID: 9555800
[TBL] [Abstract][Full Text] [Related]
49. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
[TBL] [Abstract][Full Text] [Related]
50. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
51. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
53. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
54. Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
Pourcher V; Desnoyer A; Assoumou L; Lebbe C; Curjol A; Marcelin AG; Cardon F; Gibowski S; Salmon D; Chennebault JM; Poizot-Martin I; Peytavin G; Boué F; Costagliola D
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):1-10. PubMed ID: 27405442
[TBL] [Abstract][Full Text] [Related]
55. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
[TBL] [Abstract][Full Text] [Related]
56. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
[TBL] [Abstract][Full Text] [Related]
57. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
[TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor levels in serum do not increase following HIV type 1 and HHV8 seroconversion and lack correlation with AIDS-related Kaposi's sarcoma.
Renwick N; Weverling GJ; Brouwer J; Bakker M; Schulz TF; Goudsmit J
AIDS Res Hum Retroviruses; 2002 Jul; 18(10):695-8. PubMed ID: 12167275
[TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
[TBL] [Abstract][Full Text] [Related]
60. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
